Global Closed System Drug Transfer Device (CSTD) Market 2022-2028
Description
Global Closed System Drug Transfer Device (CSTD) Market 2022-2028
According to market research study published by Gen Consulting Company, the market size of the global closed system drug transfer device sector is expected to rise by USD 5.9 billion with a CAGR of 18.3% by the end of 2028.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global closed system drug transfer device market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the closed system drug transfer device industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, delivery, end user, and region. The global market for closed system drug transfer device can be segmented by type: barrier-type, filtration-type. According to the research, the barrier-type segment had the largest share in the global closed system drug transfer device market. Closed system drug transfer device market is further segmented by delivery: closed bag and line access device, closed vial access device, closed syringe safety device. In 2021, the closed bag and line access device segment made up the largest share of revenue generated by the closed system drug transfer device market. Based on end user, the closed system drug transfer device market is segmented into: specialty center, hospital and clinic, others. Among these, the specialty center segment was accounted for the highest revenue generator in 2021. On the basis of region, the closed system drug transfer device market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America captured the largest share of the market in 2021.
Market Segmentation
By type: barrier-type, filtration-type
By delivery: closed bag and line access device, closed vial access device, closed syringe safety device
By end user: specialty center, hospital and clinic, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The global closed system drug transfer device market is highly concentrated and dominated by only a few companies: Becton, Dickinson and Company (BD), Equashield, LLC, ICU Medical Inc., Teva Pharmaceutical Industries Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
According to market research study published by Gen Consulting Company, the market size of the global closed system drug transfer device sector is expected to rise by USD 5.9 billion with a CAGR of 18.3% by the end of 2028.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global closed system drug transfer device market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the closed system drug transfer device industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, delivery, end user, and region. The global market for closed system drug transfer device can be segmented by type: barrier-type, filtration-type. According to the research, the barrier-type segment had the largest share in the global closed system drug transfer device market. Closed system drug transfer device market is further segmented by delivery: closed bag and line access device, closed vial access device, closed syringe safety device. In 2021, the closed bag and line access device segment made up the largest share of revenue generated by the closed system drug transfer device market. Based on end user, the closed system drug transfer device market is segmented into: specialty center, hospital and clinic, others. Among these, the specialty center segment was accounted for the highest revenue generator in 2021. On the basis of region, the closed system drug transfer device market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America captured the largest share of the market in 2021.
Market Segmentation
By type: barrier-type, filtration-type
By delivery: closed bag and line access device, closed vial access device, closed syringe safety device
By end user: specialty center, hospital and clinic, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The global closed system drug transfer device market is highly concentrated and dominated by only a few companies: Becton, Dickinson and Company (BD), Equashield, LLC, ICU Medical Inc., Teva Pharmaceutical Industries Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global closed system drug transfer device market.
- To classify and forecast the global closed system drug transfer device market based on type, delivery, end user, region.
- To identify drivers and challenges for the global closed system drug transfer device market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global closed system drug transfer device market.
- To identify and analyze the profile of leading players operating in the global closed system drug transfer device market.
- Gain a reliable outlook of the global closed system drug transfer device market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
Table of Contents
64 Pages
- PART 1. INTRODUCTION
- Report description
- Objectives of the study
- Market segment
- Years considered for the report
- Currency
- Key target audience
- PART 2. METHODOLOGY
- PART 3. EXECUTIVE SUMMARY
- PART 4. MARKET OVERVIEW
- Introduction
- Drivers
- Restraints
- Impact of COVID-19 pandemic
- PART 5. MARKET BREAKDOWN BY TYPE
- Barrier-type
- Filtration-type
- PART 6. MARKET BREAKDOWN BY DELIVERY
- Closed bag and line access device
- Closed vial access device
- Closed syringe safety device
- PART 7. MARKET BREAKDOWN BY END USER
- Specialty center
- Hospital and clinic
- Others
- PART 8. MARKET BREAKDOWN BY REGION
- North America
- Europe
- Asia-Pacific
- MEA (Middle East and Africa)
- Latin America
- PART 9. KEY COMPANIES
- Becton, Dickinson and Company (BD)
- Equashield, LLC
- ICU Medical Inc.
- Teva Pharmaceutical Industries Ltd.
- *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
- DISCLAIMER
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
